PDL BIOPHARMA INC. 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-05-26 4:34 pm Sale | 2020-05-21 | 13D | Evofem Biosciences, Inc. EVFM | PDL BIOPHARMA INC. PDLI | 1,778 6.300% | -7,111 (-80.00%) | Filing |